Loading data
ARVNNasdaq
| Unit: USD | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 262.6 m USD | 263.4 m USD | 78.5 m USD | 131.4 m USD | 53.6 m USD |
| Research and development expense | 285.2 m USD | 348.2 m USD | 379.7 m USD | 315 m USD | 180.4 m USD |
| Operating profit | -118.5 m USD | -250.2 m USD | -401.5 m USD | -263.2 m USD | -188.4 m USD |
| Income tax expense | 300 k USD | 600 k USD | 900 k USD | 20.9 m USD | 0 USD |
| Net income (reported basis) | -81 m USD | -199 m USD | -367 m USD | -283 m USD | -191 m USD |
| Basic earnings per share | -1.14 USD/share | -2.77 USD/share | -6.62 USD/share | -5.31 USD/share | -3.82 USD/share |
| Diluted earnings per share | -1.14 USD/share | -2.77 USD/share | -6.62 USD/share | -5.31 USD/share | -3.82 USD/share |
Quotes are end-of-day data. Content is for research purposes and is not investment advice.